BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 11929355)

  • 1. A conceptual framework for achieving performance enhancing drug compliance in sport.
    Donovan RJ; Egger G; Kapernick V; Mendoza J
    Sports Med; 2002; 32(4):269-84. PubMed ID: 11929355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes and doping: a structural equation analysis of the relationship between athletes' attitudes, sport orientation and doping behaviour.
    Petróczi A
    Subst Abuse Treat Prev Policy; 2007 Nov; 2():34. PubMed ID: 17996097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
    Morente-Sánchez J; Zabala M
    Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines.
    Smith R; Barnsley L; Kannangara S; Mace A
    Rheumatology (Oxford); 2004 Dec; 43(12):1473-5. PubMed ID: 15292526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting attitude towards performance enhancing substance use: a comprehensive test of the Sport Drug Control Model with elite Australian athletes.
    Jalleh G; Donovan RJ; Jobling I
    J Sci Med Sport; 2014 Nov; 17(6):574-9. PubMed ID: 24268440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological and social correlates of doping attitudes among Italian athletes.
    Zucchetti G; Candela F; Villosio C
    Int J Drug Policy; 2015 Feb; 26(2):162-8. PubMed ID: 25168080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of the Sport Drug Control Model with elite Australian athletes.
    Gucciardi DF; Jalleh G; Donovan RJ
    J Sci Med Sport; 2011 Nov; 14(6):469-76. PubMed ID: 21514883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidoping Science: Important Lessons From the Medical Sciences.
    Simon P; Neuberger EW; Wang G; Pitsiladis YP
    Curr Sports Med Rep; 2018 Oct; 17(10):326-331. PubMed ID: 30300193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Athletes' Doping-Related Attitudes Predicted by Their Perceptions of Coaches' Confrontation Efficacy?
    Sullivan P; Razavi P
    Subst Use Misuse; 2017 Jul; 52(8):1098-1103. PubMed ID: 28429996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivational and social cognitive predictors of doping intentions in elite sports: an integrated approach.
    Barkoukis V; Lazuras L; Tsorbatzoudis H; Rodafinos A
    Scand J Med Sci Sports; 2013 Oct; 23(5):e330-40. PubMed ID: 23574429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young athletes' awareness and monitoring of anti-doping in daily life: Does motivation matter?
    Chan DK; Donovan RJ; Lentillon-Kaestner V; Hardcastle SJ; Dimmock JA; Keatley DA; Hagger MS
    Scand J Med Sci Sports; 2015 Dec; 25(6):e655-63. PubMed ID: 25441263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Moral Foundation for Anti-Doping: How Far Have We Progressed? Where Are the Limits?
    Murray TH
    Med Sport Sci; 2017; 62():186-193. PubMed ID: 28571014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sport motivation and doping in adolescent athletes.
    Mudrak J; Slepicka P; Slepickova I
    PLoS One; 2018; 13(10):e0205222. PubMed ID: 30286200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmonization of anti-doping rules in a global context (World Anti-Doping Agency-laboratory accreditation perspective).
    Ivanova V; Miller JH; Rabin O; Squirrell A; Westwood S
    Bioanalysis; 2012 Jul; 4(13):1603-11. PubMed ID: 22831476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.